Mosapramine

	WikiDoc Resources for Mosapramine
Articles
Most recent articles on Mosapramine Most cited articles on Mosapramine Review articles on Mosapramine Articles on Mosapramine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mosapramine Images of Mosapramine Photos of Mosapramine Podcasts & MP3s on Mosapramine Videos on Mosapramine
Evidence Based Medicine
Cochrane Collaboration on Mosapramine Bandolier on Mosapramine TRIP on Mosapramine
Clinical Trials
Ongoing Trials on Mosapramine at Clinical Trials.gov Trial results on Mosapramine Clinical Trials on Mosapramine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mosapramine NICE Guidance on Mosapramine NHS PRODIGY Guidance FDA on Mosapramine CDC on Mosapramine
Books
Books on Mosapramine
News
Mosapramine in the news Be alerted to news on Mosapramine News trends on Mosapramine
Commentary
Blogs on Mosapramine
Definitions
Definitions of Mosapramine
Patient Resources / Community
Patient resources on Mosapramine Discussion groups on Mosapramine Patient Handouts on Mosapramine Directions to Hospitals Treating Mosapramine Risk calculators and risk factors for Mosapramine
Healthcare Provider Resources
Symptoms of Mosapramine Causes & Risk Factors for Mosapramine Diagnostic studies for Mosapramine Treatment of Mosapramine
Continuing Medical Education (CME)
CME Programs on Mosapramine
International
Mosapramine en Espanol Mosapramine en Francais
Business
Mosapramine in the Marketplace Patents on Mosapramine
Experimental / Informatics
List of terms related to Mosapramine

Mosapramine
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of; administration	Oral
ATC code	N05AX10 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one;
CAS Number	89419-40-9 ;
PubChem CID	4257;
ChemSpider	4107;
UNII	04UZQ7O9SJ;
KEGG	D08235 ;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C28H35ClN4O
Molar mass	479.057 g/mol
3D model (JSmol)	Interactive image;
	SMILES C1CCN2C(C1)NC(=O)C23CCN(CC3)CCCN4C5=CC=CC=C5CCC6=C4C=C(C=C6)Cl;
	InChI InChI=1S/C28H35ClN4O/c29-23-12-11-22-10-9-21-6-1-2-7-24(21)32(25(22)20-23)16-5-15-31-18-13-28(14-19-31)27(34)30-26-8-3-4-17-33(26)28/h1-2,6-7,11-12,20,26H,3-5,8-10,13-19H2,(H,30,34); Key:PXUIZULXJVRBPC-UHFFFAOYSA-N;
(verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Mosapramine (Cremin) is an atypical antipsychotic used in Japan.^[1] It is a potent dopamine antagonist with high affinity to the D₂, D₃, and D₄ receptors,^[2] and with moderate affinity for the 5-HT₂ receptors.^[3]

References

↑ Takahashi N, Terao T, Oga T, Okada M. Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. Neuropsychobiology. 1999;39(2):81-5. PMID 10072664
↑ Futamura T, Ohashi Y, Yano K, Takahashi Y, Haga K, Fukuda T. The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors. Nippon Yakurigaku Zasshi. (Japanese) 1996 May;107(5):247-53. PMID 8690306
↑ Sumiyoshi T, Suzuki K, Sakamoto H, Yamaguchi N, Mori H, Shiba K, Yokogawa K. Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy. Neuropsychopharmacology. 1995 Feb;12(1):57-64. doi:10.1016/0893-133X(94)00064-7 PMID 7766287

[1] Takahashi N, Terao T, Oga T, Okada M. Comparison of risperidone and mosapramine addition to neuroleptic treatment in chronic schizophrenia. Neuropsychobiology. 1999;39(2):81-5. PMID 10072664

[2] Futamura T, Ohashi Y, Yano K, Takahashi Y, Haga K, Fukuda T. The affinities of mosapramine for the dopamine receptor subtypes in human cell lines expressing D2, D3 and D4 receptors. Nippon Yakurigaku Zasshi. (Japanese) 1996 May;107(5):247-53. PMID 8690306

[3] Sumiyoshi T, Suzuki K, Sakamoto H, Yamaguchi N, Mori H, Shiba K, Yokogawa K. Atypicality of several antipsychotics on the basis of in vivo dopamine-D2 and serotonin-5HT2 receptor occupancy. Neuropsychopharmacology. 1995 Feb;12(1):57-64. doi:10.1016/0893-133X(94)00064-7 PMID 7766287

[1]

[2]

[3]

v t e Antipsychotics (neuroleptics) (N05A)
Typical	Benzamides: Levosulpiride • Nemonapride • Sulpiride • Sultopride • Tiapride • Veralipride; Butyrophenones: Azaperone • Benperidol • Bromperidol • Droperidol • Fluanisone • Haloperidol • Lenperone • Moperone • Pipamperone • Spiperone • Timiperone • Trifluperidol; Diphenylbutylpiperidines: Clopimozide • Fluspirilene • Penfluridol • Pimozide; Phenothiazines: Acepromazine • Acetophenazine • Butaperazine • Carphenazine • Chloracizine • Chlorproethazine • Chlorpromazine • Cyamemazine • Dixyrazine • Fluacizine • Fluphenazine • Levomepromazine/Methotrimeprazine • Mesoridazine • Perazine • Periciazine • Perphenazine • Piperacetazine • Pipotiazine • Prochlorperazine • Promazine • Promethazine • Propiomazine • Sulforidazine • Thiethylperazine • Thiopropazate • Thioproperazine • Thioridazine • Trifluoperazine • Triflupromazine; Thioxanthenes: Chlorprothixene • Clopenthixol • Flupentixol • Thiothixene • Zuclopenthixol; Tricyclics: Amoxapine • Butaclamol • Fluotracen • Loxapine • Metitepine/Methiothepin • Octoclothiepin • Trimipramine; Others: Prothipendyl
Atypical	Benzamides: Amisulpride • Remoxipride; Butyrophenones: Cinuperone • Setoperone; Benzo(iso)oxazole piperidines: Iloperidone • Ocaperidone • Paliperidone • Risperidone; Benzo(iso)thiazole piperazines: Lurasidone • Perospirone • Revospirone • Tiospirone • Ziprasidone; Diphenylbutylpiperazines: Amperozide; Phenylpiperazines: Aripiprazole • Bifeprunox • Elopiprazole • Umespirone; Tricyclics: Asenapine • Carpipramine • Clocapramine • Clotiapine • Clozapine • Fluperlapine • Gevotroline • Metitepine/Methiothepin • Mosapramine • NDMC • Olanzapine • Piquindone • Quetiapine • Tenilapine • Zotepine; Others: Blonanserin • Cariprazine • Molindone • Pimavanserin • Roxindole • Sarizotan • Sertindole • Spiramide
Others	Azacyclonol • Cannabidiol • D-Cycloserine • Lithium • Mifepristone • Oxypertine • Reserpine • Rimcazole • Secretin • Talnetant • Tetrabenazine • Vabicaserin
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III Template:Psychology navs

Clinical data


AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	N05AX10 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
IUPAC name 1'-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]hexahydro-2H-spiro[imidazo[1,2-a]pyridine-3,4'-piperidin]-2-one
CAS Number	89419-40-9^Y
PubChem CID	4257
ChemSpider	4107
UNII	04UZQ7O9SJ
KEGG	D08235^Y
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₈H₃₅ClN₄O
Molar mass	479.057 g/mol
3D model (JSmol)	Interactive image
SMILES C1CCN2C(C1)NC(=O)C23CCN(CC3)CCCN4C5=CC=CC=C5CCC6=C4C=C(C=C6)Cl
InChI InChI=1S/C28H35ClN4O/c29-23-12-11-22-10-9-21-6-1-2-7-24(21)32(25(22)20-23)16-5-15-31-18-13-28(14-19-31)27(34)30-26-8-3-4-17-33(26)28/h1-2,6-7,11-12,20,26H,3-5,8-10,13-19H2,(H,30,34) Key:PXUIZULXJVRBPC-UHFFFAOYSA-N
(verify)

Mosapramine

Overview

References

Navigation menu